IL6 and neuromyelitis optica: Uzawa et al. reported elevated serum IL-6 in NMOSD patients compared with individuals with non-inflammatory neurological diseases (ONNDs) (91), a finding corroborated by Wang et al., who observed higher plasma IL-6 in NMO patients vs. healthy controls (92, 93).